Kalaris Therapeutics KLRS Balance Sheet (2019-2026)

NASDAQ KLRS
$2.90 +0.06 (+1.93%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Kalaris Therapeutics Quarterly Balance Sheet

Periods 29 quarters
Latest Jun 2026

Kalaris Therapeutics reported total assets of $99.54M and total liabilities of $41.87M for the quarter ended Jun 2026, up 7.2% year over year. This balance sheet covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
0.28M1.00M
Receivables - AccuredAcc. Int. Receivables
0.15M0.05M0.17M0.09M0.26M0.16M0.24M0.11M0.23M0.21M0.18M0.10M0.05M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
243.19M201.66M100.21M71.09M123.83M106.09M115.70M196.95M95.63M90.12M5.23M6.24M1.91M1.64M100.97M88.43M42.39M98.05M34.43M43.17M
Receivables - OtherOther Receivables
Prepaid Assets
5.88M5.18M4.89M3.75M5.57M7.10M7.46M4.74M5.89M3.49M0.77M0.23M0.63M0.97M1.22M3.23M1.18M0.83M0.86M1.87M
Current Assets
281.87M253.35M206.44M176.52M272.04M243.05M212.28M252.91M220.02M187.63M141.48M129.94M122.53M2.61M102.18M91.65M78.18M118.81M98.47M95.92M
Non-Current Assets
Property, Plant & Equipment (Net)
1.11M1.55M1.08M1.00M0.94M0.93M0.84M0.76M0.67M
Long-Term Investments
7.65M
Other Non-Current Assets
1.21M1.10M0.98M0.86M0.85M0.85M0.85M0.85M1.43M0.85M0.55M0.55M3.15M0.50M0.69M0.98M0.95M1.75M1.73M
Non-Current Assets
34.66M33.25M24.65M23.48M21.66M34.03M31.77M29.78M28.29M3.16M2.66M1.05M3.56M0.91M1.19M2.99M2.93M11.34M3.62M
Assets
316.53M286.59M231.09M200.00M293.70M277.08M244.04M282.69M248.31M190.80M144.14M130.99M122.53M6.16M103.09M92.84M81.17M121.74M109.81M99.54M
Liabilities
Current Liabilities
Accounts Payables
0.13M8.36M4.47M5.52M4.89M3.00M4.13M5.16M3.92M6.76M0.77M0.11M0.05M1.56M2.37M3.68M0.49M1.28M0.91M1.12M
Notes Payables
19.54M
Payables
0.13M8.36M4.47M5.52M4.89M3.00M4.13M5.16M3.92M6.76M0.77M0.11M0.05M21.10M2.37M3.68M0.49M1.28M0.91M1.12M
Accumulated Expenses
15.80M20.15M10.08M13.12M13.68M13.98M12.29M16.73M15.92M10.09M4.60M1.58M1.36M2.19M2.51M3.97M5.20M8.12M6.86M7.27M
Other Accumulated Expenses
0.41M1.29M0.39M0.63M0.73M0.83M1.04M0.30M0.46M1.03M0.27M0.04M0.07M0.66M1.89M2.50M3.59M4.29M5.35M5.90M
Current Taxes
1.01M0.51M0.15M0.15M0.13M0.13M0.13M
Total Current Liabilities
24.17M37.85M18.64M21.59M20.72M24.34M24.96M30.56M33.07M28.37M7.66M2.36M1.41M24.70M7.14M7.65M6.07M9.71M8.08M8.74M
Non-Current Liabilities
Preferred Stock Liabilities
44.41M46.00M46.00M46.00M46.00M
Operating Leases
25.05M23.48M20.78M20.27M19.75M28.22M25.55M23.02M19.91M16.65M16.05M8.34M1.17M1.13M1.09M1.05M
Other Non-Current Liabilities
32.08M32.08M32.08M32.08M32.08M32.08M32.08M
Total Non-Current Liabilities
70.70M7.14M7.65M7.23M10.85M9.17M9.79M
Total Liabilities
49.23M61.33M39.41M41.86M40.47M52.56M50.51M53.58M52.98M235.81M191.68M182.51M211.91M102.78M39.22M39.73M39.31M42.92M41.25M41.87M
Shareholder's Equity
Total Debt
19.54M
Common Equity
267.30M225.27M191.68M158.14M253.23M224.52M193.53M229.11M195.33M-45.02M-47.54M-51.53M-89.38M-96.62M63.87M53.12M41.87M78.81M68.56M57.67M
Liabilities and Shareholders Equity
316.53M286.59M231.09M200.00M293.70M277.08M244.04M282.69M248.31M190.80M144.14M130.99M122.53M6.16M103.09M92.84M81.17M121.74M109.81M99.54M
Retained Earnings
-239.12M-297.06M-385.60M-385.57M-427.64M-465.77M-507.00M-552.23M-596.50M-656.19M-686.50M-692.60M-696.70M-116.60M-126.80M-138.11M-150.00M-160.00M-170.90M-182.40M

Kalaris Therapeutics Balance Sheet API

Pull Kalaris Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=KLRS&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY